Literature DB >> 23444949

Failure of treatments based on the cytokine storm theory of sepsis: time for a novel approach.

Evangelos J Giamarellos-Bourboulis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23444949     DOI： 10.2217/imt.13.8

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  5 in total

1.  Weathering the storm: Improving therapeutic interventions for cytokine storm syndromes by targeting disease pathogenesis.

Authors:  Lehn K Weaver; Edward M Behrens
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-02-07

Review 2.  Therapeutic interventions in sepsis: current and anticipated pharmacological agents.

Authors:  Prashant Shukla; G Madhava Rao; Gitu Pandey; Shweta Sharma; Naresh Mittapelly; Ranjita Shegokar; Prabhat Ranjan Mishra
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 3.  Immunotherapies for COVID-19: lessons learned from sepsis.

Authors:  Kenneth E Remy; Scott C Brakenridge; Bruno Francois; Thomas Daix; Clifford S Deutschman; Guillaume Monneret; Robin Jeannet; Pierre-Francois Laterre; Richard S Hotchkiss; Lyle L Moldawer
Journal:  Lancet Respir Med       Date:  2020-04-28       Impact factor: 30.700

4.  Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis.

Authors:  Xijie Dong; Chuntao Wang; Xinghua Liu; Wei Gao; Xiangjun Bai; Zhanfei Li
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

5.  Immune hyporeactivity to bacteria and multiple TLR-ligands, yet no response to checkpoint inhibition in patients just after meeting Sepsis-3 criteria.

Authors:  Alexandra Bick; Willem Buys; Andrea Engler; Rabea Madel; Mazen Atia; Francesca Faro; Astrid M Westendorf; Andreas Limmer; Jan Buer; Frank Herbstreit; Carsten J Kirschning; Jürgen Peters
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.